Recent News

• 06.05.2025 - Emergent BioSolutions Supports Victoria's Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies
• 06.05.2025 - Emergent BioSolutions Supports Victoria's Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies
• 05.30.2025 - NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF DERIVATIVE ACTIONS
• 05.30.2025 - NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF DERIVATIVE ACTIONS
• 05.23.2025 - Summary Notice of Pendency and Proposed Settlement of Derivative Actions
• 05.23.2025 - Summary Notice of Pendency and Proposed Settlement of Derivative Actions
• 05.14.2025 - Emergent BioSolutions to Participate in Upcoming Investor Conferences
• 05.14.2025 - Emergent BioSolutions to Participate in Upcoming Investor Conferences
• 05.07.2025 - Q1 2025 Emergent BioSolutions Inc. Earnings Conference Call
• 05.07.2025 - Q1 2025 Emergent BioSolutions Inc. Earnings Conference Call

Recent Filings

• 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 8-K Current report
• 05.23.2025 - EX-99.1 EX-99.1
• 05.23.2025 - 144 Report of proposed sale of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.07.2025 - 8-K Current report
• 05.07.2025 - EX-99.1 EX-99.1